mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.04 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.04 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.05 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.12 |
0.05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
0.06 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |